|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-04-02 |
$4.23 |
0.0% |
34,775
|
$147,076 |
|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-03-27 |
$5.11 |
0.0% |
37,000
|
$188,931 |
|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-03-20 |
$4.98 |
0.0% |
117,941
|
$587,575 |
|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-02-28 |
$4.27 |
0.0% |
336,756
|
$1,439,087 |
|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-07-30 |
$7.15 |
-4.6% |
85,800
|
$613,470 |
|
Leonard Braden Michael
|
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-07-18 |
$8.26 |
-17.4% |
216,264
|
$1,785,662 |
|
Lupher, Jr. Mark L.
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-02-07 |
$13.50 |
-49.5% |
13,000
|
$175,500 |
|
Scopa James Paul
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-02-07 |
$13.50 |
-49.5% |
10,000
|
$135,000 |
|
Rubinstein Linda M
|
Chief Financial Officer |
Adverum Biotechnologies, Inc. (ADVM)
|
2023-06-07 |
$14.55 |
-53.1% |
10,000
|
$145,490 |
|
Seyedkazemi Setareh
|
Chief Development Officer |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-05-23 |
$8.40 |
-18.8% |
2,000
|
$16,800 |
|
D'Souza Rupert
|
Chief Financial Officer |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-05-17 |
$8.43 |
-19.1% |
2,000
|
$16,857 |
|
Beckman Richard
|
Chief Medical Officer |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-05-17 |
$8.23 |
-17.1% |
1,000
|
$8,228 |
|
Svoronos Dawn
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-05-16 |
$8.53 |
-20.0% |
3,000
|
$25,578 |
|
Fischer Laurent
|
CEO |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-04-20 |
$11.12 |
-38.7% |
2,500
|
$27,800 |
|
Soparkar Peter
|
Check Filing |
Adverum Biotechnologies, Inc. (ADVM)
|
2022-04-19 |
$11.40 |
-40.2% |
2,192
|
$24,994 |
|
Fischer Laurent
|
CEO |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-12-09 |
$18.24 |
-62.6% |
2,500
|
$45,609 |
|
Soparkar Peter
|
Check Filing |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-12-08 |
$19.10 |
-64.3% |
2,500
|
$47,750 |
|
Svoronos Dawn
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-03-31 |
$100.17 |
-93.2% |
2,000
|
$200,338 |
|
Machado Patrick
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-03-24 |
$99.20 |
-93.1% |
1,000
|
$99,196 |
|
Fischer Laurent
|
CEO and Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-03-24 |
$98.78 |
-93.1% |
1,000
|
$98,780 |
|
Fischer Laurent
|
CEO and Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-01-15 |
$115.34 |
-94.1% |
860
|
$99,191 |
|
Machado Patrick
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2021-01-15 |
$115.17 |
-94.1% |
1,000
|
$115,174 |
|
Fischer Laurent
|
CEO and Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2020-08-17 |
$130.00 |
-94.8% |
769
|
$99,996 |
|
Soparkar Peter
|
Chief Legal Officer |
Adverum Biotechnologies, Inc. (ADVM)
|
2020-08-17 |
$130.00 |
-94.8% |
769
|
$99,996 |
|
Scopa James Paul
|
Non-Executive Director |
Adverum Biotechnologies, Inc. (ADVM)
|
2020-02-14 |
$137.50 |
-95.0% |
1,000
|
$137,500 |